SCHEMBL7008122

SCHEMBL7008122

CC(=O)C1Cc2cc([N+](=O)[O-])ccc2NC1C

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PNMT P11086 7/20 0.47
ADRA2A P08913 4/20 0.47
ADRA2B P18089 3/20 0.47
ADRA2C P18825 3/20 0.47
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.43
GAA P10253 1/20 0.41
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
GAPDH P04406 1/20 0.39
HSPA1A P0DMV8 1/20 0.39
HSPA8 P11142 1/20 0.39
CD44 P16070 1/20 0.39
MSN P26038 1/20 0.39
PTPN7 P35236 1/20 0.39
EZH2 Q15910 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968655 0.80 ALDH1A1 (0.62) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL257552 0.80 ALDH1A1 (0.62) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL10293160 0.76 GAA (0.54) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL16115726 0.76 GAA (0.54) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL29697818 0.76 GAA (0.54) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL28788156 0.75 MAPT (0.46) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL20939589 0.75 PNMT (0.43) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL26597092 0.75 MAPT (0.46) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL28239780 0.74 PNMT (0.47) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL6966089 0.73 PNMT (0.50) PNMTADRA2AADRA2BADRA2CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363909-A2 TRICYCLIC ANDROGEN RECEPTOR MODULATOR COMPOUNDS LIGAND PHARMACEUTICALS INCORPORATED (US) 2003-11-26 EP disclosed
WO-2002066475-A2 TRICYCLIC ANDROGEN RECEPTOR MODULATOR COMPOUNDS LIGAND PHARMACEUTICALS INCORPORATED (US) 2002-08-29 WO disclosed